The Regulator's Broader Message Beyond the immediate prohibition, CDSCO used the advisory to make a broader public health point: obesity is a chronic metabolic condition that requires comprehensive management, including lifestyle interventions such as diet, exercise, and behavioural change
Rabobank: Its way too early to draw conclusions However, Nick Fereday, senior analyst, consumer foods at Rabobank, says we should be careful about making sweeping predictions about the future of the food industry based on preliminary survey data from a relatively small number of GLP-1 drug users
healthcare spending reached USD 4.9 trillion in 2023, representing 17.6% of GDP , highlighting the region's strong healthcare investment environment that supports the adoption of wellness and infusion-based therapies
The FDA officially removed tirzepatide from the shortage list in December 2024 and removed semaglutide in February 2025
* Correspondence: Debarshi Ghosh, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers